SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-043683
Filing Date
2023-08-21
Accepted
2023-08-21 16:05:34
Documents
12
Period of Report
2023-08-17
Items
Item 1.02: Termination of a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K sana-20230817.htm   iXBRL 8-K 61461
  Complete submission text file 0000950170-23-043683.txt   189187

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sana-20230817_pre.xml EX-101.PRE 11544
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sana-20230817_lab.xml EX-101.LAB 18527
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sana-20230817.xsd EX-101.SCH 2450
6 EXTRACTED XBRL INSTANCE DOCUMENT sana-20230817_htm.xml XML 4890
Mailing Address 188 EAST BLAINE STREET, SUITE 400 SEATTLE WA 98102
Business Address 188 EAST BLAINE STREET, SUITE 400 SEATTLE WA 98102 (206) 701-7914
Sana Biotechnology, Inc. (Filer) CIK: 0001770121 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39941 | Film No.: 231189156
SIC: 2836 Biological Products, (No Diagnostic Substances)